Literature DB >> 2153712

Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide.

C Boulanger1, T F Lüscher.   

Abstract

This study was designed to examine whether endothelin is released from the intima of intact arteries, and whether endothelium-derived nitric oxide regulates its production. Endothelin was detected in the incubating medium of unstimulated pig aortae with, but not in those without endothelium. In preparations with endothelium, thrombin (2-6 U/ml) and the calcium ionophore A23187 (10(-6) M) stimulated the release of the peptide. The basal and thrombin-stimulated production of endothelin were prevented by the protein synthetase inhibitor cycloheximide (10(-6) M). The production of endothelin upon stimulation with thrombin (4 U/ml) was potentiated by L-NG-monomethyl arginine and methylene blue and reduced by superoxide dismutase and 8-bromo cyclic guanosine 5'-monophosphate (GMP), while the basal release of the peptide was unaffected. Thus, (a) endothelin is released from the intimal layer of intact blood vessels, both under basal conditions and after stimulation with thrombin and the calcium ionophore A23187, and (b) endothelium-derived nitric oxide released during stimulation with thrombin inhibits the production of the peptide via a cyclic GMP-dependent pathway.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153712      PMCID: PMC296463          DOI: 10.1172/JCI114477

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Platelets, endothelium, and vasospasm.

Authors:  P M Vanhoutte; D S Houston
Journal:  Circulation       Date:  1985-10       Impact factor: 29.690

2.  Blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation of rabbit aorta by certain ferrous hemoproteins.

Authors:  W Martin; G M Villani; D Jothianandan; R F Furchgott
Journal:  J Pharmacol Exp Ther       Date:  1985-06       Impact factor: 4.030

3.  Characterization of a coronary vasoconstrictor produced by cultured endothelial cells.

Authors:  K A Hickey; G Rubanyi; R J Paul; R F Highsmith
Journal:  Am J Physiol       Date:  1985-05

4.  Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor.

Authors:  R J Gryglewski; R M Palmer; S Moncada
Journal:  Nature       Date:  1986 Apr 3-9       Impact factor: 49.962

5.  Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor.

Authors:  G M Rubanyi; P M Vanhoutte
Journal:  Am J Physiol       Date:  1986-05

6.  Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP.

Authors:  R M Rapoport; F Murad
Journal:  Circ Res       Date:  1983-03       Impact factor: 17.367

7.  Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats.

Authors:  T F Lüscher; L Raij; P M Vanhoutte
Journal:  Hypertension       Date:  1987-02       Impact factor: 10.190

8.  Mechanisms of adenosine triphosphate-, thrombin-, and trypsin-induced relaxation of rat thoracic aorta.

Authors:  R M Rapoport; M B Draznin; F Murad
Journal:  Circ Res       Date:  1984-10       Impact factor: 17.367

9.  Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization.

Authors:  R K Assoian; A Komoriya; C A Meyers; D M Miller; M B Sporn
Journal:  J Biol Chem       Date:  1983-06-10       Impact factor: 5.157

10.  Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid.

Authors:  L J Ignarro; R G Harbison; K S Wood; P J Kadowitz
Journal:  J Pharmacol Exp Ther       Date:  1986-06       Impact factor: 4.030

View more
  141 in total

1.  Endothelin mediates renal vascular memory of a transient rise in perfusion pressure due to NOS inhibition.

Authors:  X Z Zhang; C Baylis
Journal:  Am J Physiol       Date:  1999-04

Review 2.  Effects of antihypertensive drugs on endothelial dysfunction: clinical implications.

Authors:  Stefano Taddei; Agostino Virdis; Lorenzo Ghiadoni; Isabella Sudano; Antonio Salvetti
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 3.  Cardiovascular impact of drugs used in the treatment of diabetes.

Authors:  Chris R Triggle; Hong Ding
Journal:  Ther Adv Chronic Dis       Date:  2014-11       Impact factor: 5.091

Review 4.  Bosentan and the endothelin system in congestive heart failure.

Authors:  S H Ellahham; V Charlon; Z Abassi; K A Calis; W K Choucair
Journal:  Clin Cardiol       Date:  2000-11       Impact factor: 2.882

Review 5.  Reactive oxygen and nitrogen species in pulmonary hypertension.

Authors:  Diana M Tabima; Sheila Frizzell; Mark T Gladwin
Journal:  Free Radic Biol Med       Date:  2012-03-06       Impact factor: 7.376

6.  Endothelial nitric oxide synthase gene polymorphisms in non-arteritic anterior ischemic optic neuropathy.

Authors:  Tsutomu Sakai; Keigo Shikishima; Masato Matsushima; Kenji Kitahara
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-02       Impact factor: 3.117

Review 7.  Endothelial dysfunction in diabetes: multiple targets for treatment.

Authors:  Hong Ding; Chris R Triggle
Journal:  Pflugers Arch       Date:  2010-03-18       Impact factor: 3.657

Review 8.  Mechanisms of action of nitrates.

Authors:  K E Torfgård; J Ahlner
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

Review 9.  Role of endothelin-1 in hypertension.

Authors:  Marc Iglarz; Ernesto L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

10.  Vascular responses to endothelin-1 following inhibition of nitric oxide synthesis in the conscious rat.

Authors:  J G Filep; E Földes-Filep; A Rousseau; P Sirois; A Fournier
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.